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PERSPECTIVE ON THE USE OF LNT FOR RADIATION PROTECTION AND
RISK ASSESSMENT BY THE U.S. ENVIRONMENTAL PROTECTION AGENCY

Jerome S. Puskin, PhD 䊐 Center for Science and Technology, Radiation
Protection Division, ORIA (6608J), EPA, Washington, DC
䊐 The U.S. Environmental Protection Agency (EPA) bases its risk assessments, regulatory limits, and nonregulatory guidelines for population exposures to low level ionizing radiation on the linear no-threshold (LNT) hypothesis, which assumes that the risk of cancer
due to a low dose exposure is proportional to dose, with no threshold. The use of LNT for
radiation protection purposes has been repeatedly endorsed by authoritative scientific
advisory bodies, including the National Academy of Sciences’ BEIR Committees, whose
recommendations form a primary basis of EPA’s risk assessment methodology. Although
recent radiobiological findings indicate novel damage and repair processes at low doses,
LNT is supported by data from both epidemiology and radiobiology. Given the current
state of the science, the consensus positions of key scientific and governmental bodies, as
well as the conservatism and calculational convenience of the LNT assumption, it is
unlikely that EPA will modify this approach in the near future.

INTRODUCTION

The U.S. Environmental Protection Agency (EPA) is responsible for
protecting the public from environmental exposures to radiation. To
meet this objective the Agency sets regulatory limits on radionuclide concentrations in air, water, and soil. In other cases (e.g., for residential
radon) it may establish nonregulatory guidelines for radionuclides. The
purpose of these limits and guidelines is to prevent health effects and to
establish an acceptable level of safety for members of the public, the primary concern being the minimization of radiogenic cancers.
Setting protective exposure limits and providing appropriate guidance requires an assessment of risks. Periodically, EPA updates its radiation risk models. In this process, EPA derives most of its assumptions and
models from reports by scientific advisory bodies including the U.S.
National Academy of Sciences, the International Commission on
Radiological Protection (ICRP), the United Nations Scientific Committee
on the Effects of Ionizing Radiation (UNSCEAR), and the National
Council on Radiation Protection and Measurements (NCRP), with additional input from its own independent review of the scientific literature.
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284

Published by ScholarWorks@UMass Amherst, 2014

1

Dose-Response: An International Journal, Vol. 7 [2014], Iss. 4, Art. 1

Perspective on the use of LNT for radiation protection and risk assessment by the U.S. EPA

To assist the Agency in its assessment of the health risks from ionizing
radiation, EPA has often helped sponsor reports from these organizations, particularly from the NAS “BEIR Committees.” The risk models
and supporting evidence is then reviewed by EPA’s Scientific Advisory
Board of outside distinguished scientists before becoming final and being
implemented. Thus, EPA’s estimates of risk to low dose radiation reflect
a broad scientific consensus.
Based on extensive epidemiological and laboratory studies, radiation
is a well-established human carcinogen; however, with the notable exception of radon exposures in homes, environmental levels of radiation are
too low to produce detectable excess cancers in epidemiological studies.
As a consequence, risks have to be extrapolated from results of epidemiological studies on more highly exposed individuals. A similar situation
exists in connection with EPA’s assessments of risk from chemical carcinogens: the cancer risk due to intake of a chemical is extrapolated from
studies at higher doses. In the case of chemicals there is usually an additional extrapolation from laboratory animals to humans. For radiation, at
least, there are direct human data upon which we can establish that it
causes cancer and from which the magnitude of the risk at environmental doses can be projected, even if that estimated risk is too small to be
observed.
Radiation protection, like the regulation of other carcinogenic
agents, is—in the absence of compelling evidence to the contrary—predicated on the linear, no-threshold (LNT) hypothesis, which assumes that
the risk of cancer due to a low dose exposure is proportional to dose, with
no threshold.
More specifically, it is common practice to project radiogenic cancer
risk due to exposures of low level, ionizing radiation by a linear extrapolation of the dose response function observed for more highly exposed
cohorts, especially the Life Span Study (LSS) cohort of Japanese atomic
bomb survivors. For low-LET radiation, a dose/dose rate effectiveness factor (DDREF) is usually incorporated to reflect evidence that the risk coefficient for acute doses of ≈ 0.5 Gy is higher than what it would be for lower
dose exposures or for exposures at low dose rates. The National Academy
of Sciences BEIR VII committee (NRC 2006) recently estimated that the
relevant DDREF for solid tumor induction is about 1.5: i.e., the risk at low
doses and low dose rates is expected to be only about a factor of 1.5 times
lower than that projected from a simple linear fit to the LSS data.
Is this approach for extrapolating risk justified from a scientific standpoint? Is it reasonable from a radiation protection standpoint? What
would it take to justify a change in this approach for the purposes of radiation protection or of radiation risk estimation, more broadly?
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SCIENTIFIC PERSPECTIVE

Results from laboratory studies of irradiated animals and epidemiological studies of irradiated human cohorts are generally consistent with
a linear, no-threshold dose-response, down to the lowest doses for which
there is statistical power to measure (Brenner et al. 2003). For low-LET
radiation, however, even the largest epidemiology studies are only sensitive down to incremental doses of ~100 mGy above background. At this
dose, each cell nucleus is traversed by ~100 electron tracks. In comparison, at natural background levels, each cell nucleus is traversed by only
on the order of 1 track per year. There is, nevertheless, a theoretical basis
for excluding a threshold and for extrapolating the linear dose-response
relationship to very low doses where the radiogenic damage is caused by
single tracks.
First, traversal of cells by energetic charged particles produces ionizations and molecular excitations resulting in chemical damage to the DNA.
Significantly, even low-LET radiation, for which the energy deposition
events are, on average, more widely spaced, produces a substantial fraction
of its DNA damage in the form of “clusters” or “multiply-damaged sites”
(usually at the ends of electron tracks), which are difficult or impossible
for the cell to repair faithfully (Goodhead 1994). Second, it appears that
a single mutation in a cell can increase the probability that the cell will
become malignant. Lastly, a foolproof biological mechanism for screening
out malignant or pre-malignant cells appears to be ruled out by the high
rate of cancer observed in the population. These mechanistic features of
radiation carcinogenesis argue against a strict dose threshold below which
there would be no risk of a radiation-induced cancer.
Although a strict threshold appears unlikely, mechanisms may exist to
modulate risks at very low doses in such a way that actual risks are substantially below those projected by LNT. In effect, we might then have a
“practical threshold”—i.e., a dose below which the risk becomes negligible
from a regulatory perspective. Before such a threshold is accepted for radiation protection purposes, however, there would almost certainly be a
need for confirmation with human epidemiological data—or, at least, with
some kind of biomarkers in human tissues that clearly relate to cancer.
Radiobiological research has recently focused on a number of lowdose effects, including the adaptive response (Azzam et al. 1996, Redpath
and Antoniono 1998, Tapio and Jacob 2007), bystander effects
(Mothersill and Seymour 1998, Nagasawa and Little 1999, Mitchell et al.
2004), and genomic instability (Morgan et al. 1996, Little et al. 1997),
which might provide mechanisms whereby the linearity of the doseresponse relationship would break down at low doses. In principle, the
risk per unit dose could plausibly be either increased or decreased
through these mechanisms. For example, bystander effects refer to
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changes in unirradiated cells due to irradiation of nearby cells. Such
changes may, in principle, be either harmful (e.g., by producing carcinogenic mutations in bystander cells) or protective (e.g., by stimulating
repair or by inducing apoptosis of damaged cells). At this time, it is
unclear whether or not any of these phenomena have an appreciable
effect on the in vivo dose-response for ionizing radiation (NRC 2006).
Even the largest epidemiological studies lack the power to detect lowLET radiation risks unless the incremental dose above background is
about 0.1 Gy or higher. Nevertheless, epidemiological studies of groups
receiving fractionated or chronic exposures may shed light on risks at
substantially lower doses (Puskin 2008). For example, studies have been
carried out on scoliosis and TB patients (Doody et al. 2000, Howe and
McLaughlin 1996), who received multiple diagnostic x-ray exposures of
less than 10 mGy each, separated by more than a week. At these x-ray
doses, no cell nucleus is traversed by more than a few radiation tracks during a single examination. As a consequence, the relevant DNA damage is
expected to have been produced solely by single tracks. A positive dose
response for cancer induction has been observed in both the scoliosis
and TB patients. Moreover, the slope of the dose-response in the TB
patients is remarkably consistent with that observed for breast cancer in
the LSS (Howe and McLaughlin 1996). These results argue against an
effective threshold—even at ~ 1 track per cell nucleus.
Even more sensitive tests for a low-dose practical threshold might be
obtained through epidemiological studies of cohorts receiving chronic
radiation exposures, either environmentally or occupationally. There are
a number of such cohorts being investigated, notably: the population
around Chernobyl (Hatch et al. 2005), Chernobyl cleanup workers
(Hatch et al. 2005), people living downriver from the Mayak Plutonium
Plant (Ostroumova et al. 2006, Krestinina et al. 2005), the population
residing near the Semipalatinsk nuclear test site in Kazakhstan (Bauer et
al. 2005), occupants of 60Co-contaminated buildings in Taiwan (Hwang et
al. 2008), and cohorts of workers from the nuclear industry and nuclear
shipyards (Cardis et al. 2007, Muirhead et al. 2009, Schubauer-Berigan et
al. 2007). Such studies can potentially provide evidence regarding risk at
exposure rates of 0.1-1 mGy/day, corresponding to 0.1-1 ionizing track
per cell nucleus per day, or even lower (Puskin 2008). Statistically significant positive associations between radiation dose and cancer incidence
have been found for a number of these cohorts. A recent meta analysis of
epidemiological studies of subjects exposed to chronic, moderate doses
of radiation indicated that the risk per unit dose was about the same as
that found in the LSS cohort (Jacob et al. 2009). Results are still somewhat preliminary, and improvements in both dosimetry and epidemiological follow-up are anticipated. If these findings do hold up, it would
indicate that a practical threshold could only exist at very low daily doses,
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which would put severe restrictions on any proposed biological mechanism (Puskin 2008).
REGULATORY PERSPECTIVE

LNT has long been accepted as the basis for assessing risks from ionizing radiation. This approach has been repeatedly endorsed by National
Academy of Sciences (NAS) “BEIR” committees, beginning with the 1972
BEIR Report (NRC 1972) and by the International Commission on
Radiological Protection (ICRP), the National Council on Radiation
Protection and Measurement (NCRP), and the United Nations Scientific
Committee on the Effects of Atomic Radiation (UNSCEAR). More generally, a 1985 policy directive from the Office of Science and Technology
Policy (OSTP 1985) establishes the linear, no-threshold assumption as the
default method for extrapolating cancer risks to low doses for the U.S.
government. A recent directive by the U.S. Environmental Protection
Agency allows deviation from the LNT approach (EPA 2005), but only in
cases where there is strong scientific support for a mode of action that
would give rise to a different dose-response relationship. In view of these
recommendations and the supporting science, EPA has consistently
applied LNT as part of its regulatory and risk assessment framework for
radiation.
The use of LNT for radiation protection purposes is often justified as
being “conservative”; i.e., it is presumed that, while we may not be able to
estimate the risk at low doses accurately, linear extrapolation is unlikely
to (greatly) underestimate risk. Hence, if radiation standards are promulgated under the assumption that LNT is correct, they will be protective.
LNT also has the great advantage of simplicity, risks from multiple exposures being proportional to the total dose. Given these features of protectiveness and convenience, there is very wide support for LNT in the
context of radiation protection, even among scientists and regulators who
harbor serious doubts about its scientific validity.
It is difficult to imagine any relaxation in this approach unless there
is convincing evidence that LNT greatly overestimates risk at the low
doses of interest. For example, before EPA would adopt a “threshold” for
regulatory purposes, there would probably have to be a strong recommendation to that effect from authoritative bodies such as a National
Academy of Sciences’ BEIR committee, endorsed by the Agency’s
Scientific Advisory Board, with ample opportunities for public comment
and Agency response. No such change can be expected soon in view of
the recent BEIR VII Committee’s position that “the balance of evidence
from epidemiologic, animal and mechanistic studies tend to favor a simple proportionate relationship at low doses between radiation dose and
cancer risk” (BEIR VII, p. 14).
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Even if a practical threshold could be convincingly demonstrated, it
remains unclear what effect this would have on radiation protection. A
threshold lower than the level of radiation received from unavoidable
sources would obviously have no impact on regulations. Demonstration
of a practical threshold substantially above background might allow certain regulations to be relaxed or reinterpreted. Examples might include
derived soil cleanup levels for Superfund sites and maximum allowed
concentrations of radionuclides in drinking water. However, a number of
issues would have to be considered in setting threshold-based standards,
including the uncertainty in the threshold dose, the possible existence of
sensitive subpopulations, and the contribution of multiple sources. Such
considerations would likely dictate that a sizable safety factor be incorporated to ensure that a sufficiently large fraction of the population would
fall below the threshold. For example, even if it were to be demonstrated
that a dose rate of 10 mGy per year posed negligible risk to the great
majority of people, the regulatory limit on a given source might still be
set substantially lower than this.
Opposition to the LNT approach for radiation protection, in some
cases, arises from concerns that the presumption of finite risk, even at
background levels of exposures, generates unreasonable fears among
members of the public, which may cause them to reject nuclear power or
other useful technologies, such as diagnostic medical procedures. At the
very least, basing radiation protection on the LNT assumption may
impose large economic costs on the nuclear industry and on those footing the bill for cleanup of radioactively contaminated sites. Nevertheless,
unless compelling evidence for a practical threshold can be obtained, it
must be acknowledged that there is likely to be a risk even at the lowest
doses of ionizing radiation. Denials only fuel distrust. It is better to
acknowledge that the science, so far, is consistent with a non-zero risk at
low doses, even if direct verification is lacking.
It can also be pointed out that LNT implies that risks at low doses are
very low, providing reasonable assurance that current radiation protection measures, based on the LNT assumption, are adequately protective.
In addition, it should be emphasized that any large-scale technology
imposes some risk and that alternative technologies should be compared
in terms of their respective benefits, health risks, environmental impact,
and economic costs. In particular, electrical power generation based on
nuclear reactors and on burning of fossil fuels should be evaluated in
terms of: (1) their relative contributions to global warming and (2) their
potential health impacts due to release of hazardous chemicals and
radionuclides into the environment.
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